EA003393B1 - Композиции пароксетина - Google Patents

Композиции пароксетина Download PDF

Info

Publication number
EA003393B1
EA003393B1 EA200000977A EA200000977A EA003393B1 EA 003393 B1 EA003393 B1 EA 003393B1 EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A EA200000977 A EA 200000977A EA 003393 B1 EA003393 B1 EA 003393B1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetine
solvent
pharmaceutically acceptable
acceptable derivative
solid carrier
Prior art date
Application number
EA200000977A
Other languages
English (en)
Russian (ru)
Other versions
EA200000977A1 (ru
Inventor
Эндрю Симон Крэйг
Нил Уорд
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000977A1 publication Critical patent/EA200000977A1/ru
Publication of EA003393B1 publication Critical patent/EA003393B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA200000977A 1998-03-24 1999-03-24 Композиции пароксетина EA003393B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (2)

Publication Number Publication Date
EA200000977A1 EA200000977A1 (ru) 2001-02-26
EA003393B1 true EA003393B1 (ru) 2003-04-24

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000977A EA003393B1 (ru) 1998-03-24 1999-03-24 Композиции пароксетина

Country Status (20)

Country Link
EP (1) EP1063993A1 (ja)
JP (1) JP2002507569A (ja)
CN (1) CN1125639C (ja)
AP (1) AP2000001914A0 (ja)
AU (1) AU754765B2 (ja)
BG (1) BG104865A (ja)
BR (1) BR9908991A (ja)
CA (1) CA2324612A1 (ja)
EA (1) EA003393B1 (ja)
GB (1) GB9806312D0 (ja)
HU (1) HUP0101326A3 (ja)
ID (1) ID26485A (ja)
IL (1) IL138478A0 (ja)
NO (1) NO313404B1 (ja)
NZ (1) NZ506893A (ja)
PL (1) PL343095A1 (ja)
SK (1) SK14102000A3 (ja)
TR (1) TR200002750T2 (ja)
WO (1) WO1999048499A1 (ja)
ZA (1) ZA200005697B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
WO2005002541A2 (en) * 2003-07-02 2005-01-13 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403A2 (en) * 1985-10-25 1987-05-27 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
DE19603797A1 (de) * 1995-02-06 1996-08-14 Smithkline Beecham Plc Neue Formen von Paroxetin-Hydrochlorid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403A2 (en) * 1985-10-25 1987-05-27 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
DE19603797A1 (de) * 1995-02-06 1996-08-14 Smithkline Beecham Plc Neue Formen von Paroxetin-Hydrochlorid
WO1996024595A1 (en) * 1995-02-06 1996-08-15 Smithkline Beecham Plc New forms of paroxetin hydrochloride

Also Published As

Publication number Publication date
NO20004740L (no) 2000-10-03
CA2324612A1 (en) 1999-09-30
ID26485A (id) 2001-01-11
SK14102000A3 (sk) 2001-03-12
IL138478A0 (en) 2001-10-31
WO1999048499A1 (en) 1999-09-30
HUP0101326A2 (hu) 2002-05-29
PL343095A1 (en) 2001-07-30
AP2000001914A0 (en) 2000-09-30
HUP0101326A3 (en) 2002-06-28
EA200000977A1 (ru) 2001-02-26
CN1294512A (zh) 2001-05-09
JP2002507569A (ja) 2002-03-12
ZA200005697B (en) 2001-10-02
GB9806312D0 (en) 1998-05-20
NO20004740D0 (no) 2000-09-22
NO313404B1 (no) 2002-09-30
AU754765B2 (en) 2002-11-21
NZ506893A (en) 2003-06-30
BR9908991A (pt) 2000-12-12
TR200002750T2 (tr) 2000-12-21
AU3045199A (en) 1999-10-18
EP1063993A1 (en) 2001-01-03
BG104865A (en) 2001-05-31
CN1125639C (zh) 2003-10-29

Similar Documents

Publication Publication Date Title
KR0183027B1 (ko) 류코트리엔의 작용에 대한 길항작용이 요구되는 질환의 치료용 약학 조성물 및 이의 제조 방법
JP6173521B2 (ja) ナルブフィンを含有する製剤及びそれらの使用
AU2010297357B2 (en) (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
RU2349306C2 (ru) Лекарственные средства, содержащие тригидрат гидрохлорида варденафила
JPH0768140B2 (ja) 安定化された医薬物質、その製法および安定な医薬製剤
EP1905424A2 (en) Pharmaceutical composition comprising stabilized statin particles
JP2005501074A (ja) パロキセチン・グリチルリチン酸塩
UA75135C2 (en) Dry granulation method for manufacturing pharmaceutical composition containing tetrahydronaphthalene-2-ol derivative and low dosage tablet compositions
EA003393B1 (ru) Композиции пароксетина
CN102947300B (zh) 生物碱氨基酯衍生物及其药物组合物
US6699882B2 (en) Paroxetine compositions
JP2002532429A (ja) 薬学的処方物
KR20010042145A (ko) 파록세틴 조성물
AU2003200534B2 (en) Paroxetine compositions
KR100896563B1 (ko) 축합 인돌 화합물을 포함하는 제약 조성물
MXPA00009340A (en) Paroxetine compositions
CZ20003489A3 (cs) Paroxetinové kompozice
JPH11349475A (ja) 口腔内崩壊錠及びその製造法
CN103860473A (zh) 一种度洛西汀药物组合物
JP2024045113A (ja) 化合物及びフマル酸の結晶形態、医薬組成物及びコロナウイルス誘発性疾患の治療方法
CN1306530A (zh) 用于治疗中枢神经系统疾病的帕罗西汀10－樟脑磺酸盐
JP2013035770A (ja) 安定化された医薬組成物
MXPA00011154A (en) Novel formulation containing paroxetine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU